4.71BMarket Cap33.46P/E (TTM)
23.380High22.670Low1.27MVolume23.100Open23.130Pre Close28.93MTurnover1.49%Turnover Ratio61.49P/E (Static)206.97MShares27.11552wk High1.84P/B1.93BFloat Cap11.89052wk Low--Dividend TTM84.83MShs Float27.115Historical High--Div YieldTTM3.07%Amplitude8.750Historical Low22.824Avg Price1Lot Size
Life Time Stock Forum
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology (CLVS.US)$ +11.3%, $Cardiff Oncology (CRDF.US)$ +9%, $Immatics (IMTX.US)$ +8.3%, $IDEAYA Biosciences (IDYA.US)$ +8%, $Lyra Therapeutics (LYRA.US)$ +5.7%, $POINT Biopharma (PNT.US)$ +5.7%, $Edgewise Therapeutics (EWTX.US)$ +4.7%, $Concert Pharmaceuticals (CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals (DCPH.US)$ +3.2%, $Veracyte (VCYT.US)$ +2.6%, $SpringWorks Therapeutics (SWTX.US)$ +2.3%, ...
No comment yet